Innovation & Adherence: Two Paths to Better Controlling Diabetes
Washington, D.C. (November 13, 2012) — America’s biopharmaceutical research companies currently are developing 221 innovative new medicines to help the nearly 26 million patients in the United States affected by diabetes.
Washington, D.C. (December 3, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today on the President’s Council of Advisors on Science and Technology (PCAST) report:
Medical Innovation Top Priority for Likely Voters in U.S.
10.29.12 | By
We are very pleased to feature a guest blog post from Mary Woolley, President and CEO, Research!America, about support for medical innovation and why it is an important issue for the majority of likely voters during this year's election.
Washington, D.C. (September 13, 2012)— The Pharmaceutical Research and Manufacturers of America (PhRMA) released two new reports at its first annual Research and Hope Awards ceremony, which celebrated advancements made in research and patient care for Alzheimer’s disease. The reports detail how obstacles play a role in moving Alzheimer’s research forward, as well as the progress that is being made to help confront this complicated disease.